Founder and Recurrent CDH1 Mutations in Families With Hereditary Diffuse Gastric CancerPardeep Kaurah, David G. Huntsman, Andrée MacMillan et al.|JAMA|2007Cited by 455
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGSMelissa C. Southey, Helen Tsimiklis, Fabrice Odefrey et al.|Journal of Medical Genetics|2016Cited by 217
Consensus for genes to be included on cancer panel tests offered by UK genetics services: guidelines of the UK Cancer Genetics GroupAmy Taylor, Lucy Side, Angela F. Brady et al.|Journal of Medical Genetics|2018Cited by 101
Clinical likelihood ratios and balanced accuracy for 44 in silico tools against multiple large-scale functional assays of cancer susceptibility genesClare Turnbull, Alice Garrett, Subin Choi et al.|Genetics in Medicine|2021Cited by 82
Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)Helen Hanson, Douglas R. Stewart, Esteban Astiazarán-Symonds et al.|Genetics in Medicine|2023Cited by 79